A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine

Blood Pressure Monitoring

Volumn 3, Issue 5, 1998, Pages 295-302

  Lacourcière, Yves ^a   Lenis, Jacques ^b   Orchard, Robert ^c   Lewanczuk, Richard ^d   Houde, Marc ^b   Pesant, Yves ^b   Wright, James ^e   Wilson, Thomas ^f   Martin, Kathryn ^g  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Midtown Medical Centre   (Canada)

^d ALBERTA ENVIRONMENT AND PARKS   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f ROYAL UNIVERSITY HOSPITAL   (Canada)

^g BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

Ambulatory blood pressure monitoring; Amlodipine; Angiotensin II antagonist; Calcium antagonist; Telmisartan

Indexed keywords

AMLODIPINE; ANGIOTENSIN II ANTAGONIST; PLACEBO; TELMISARTAN;

AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032423365     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Laragh JH. Historical perspective on renin system blockade in the treatment of hypertension. Am J Hypertens 1992; 5 (12 pt 2):207S-208S.
2. Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg Al, Nelson EB. Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med 1995; 155:405-411.
3. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, Snavely DB, Sweet CS. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25:1345-1350.
4. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996; 156:278-285.
5. Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Br J Pharmacol 1993; 110:245-253.
6. Wong PC, Price WA, Chiu AT, Duncia JV, Canni DJ, Wexler RR, et al. Nonpeptide angiotensin II antagonists. XI. Pharmacology of EXP 3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990; 255:211-217.
7. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993; 153:154-183.
8. Heber ME, Brigden G, Al-Khawaja I, Raftery EB. 24 H blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989; 27:359-365.
9. Lacourcière Y, Poirier L, Provencher P. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring. J Cardiovasc Pharmacol 1993; 22 (suppl A):S20-S23.
10. Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cleroux J, Boileau G. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension. Am J Hypertens 1995; 8:1154-1159.
11. O'Brien E, O'Malley K, Cox J, Stanton A. Ambulatory blood pressure monitoring in the evaluation of drug efficacy. Am Heart J 1991; 121:999-1006.
12. Neutel JM, Smith DH, Ram CV, Kaplan NM, Papademetriou V, Fagan TC, et al. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 1993; 94:181-187.
13. Frick MH, McGibney D, Tyler HM. A dose-response study of amlodipine in mild to moderate hypertension. J Intern Med 1989; 225:101-105.
14. Shih WJ, Gould AL, Hwang IK. The analysis of titration studies in phase III clinical trials. Stat Med 1989; 8:583-591.
15. White WB. Clinical relevance of ambulatory versus clinic blood pressure when evaluating antihypertensive therapy. Blood Press Monit 1996; 1:120-123.
16. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A Ambulatory blood pressure normality: results from the PAMELA Study. J Hypertens 1995; 13:1377-1390.
17. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
18. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118:782-785.
19. Rose M, McMahon FG. Some problems with antihypertensive drug studies in the context of new guidelines. Am J Hypertens 1990; 3:151-155.
20. Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J. Efficacy, tolerability, and effects of quality of life of losartan, alone or with hydrochloro-thiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. Clin Ther 1996; 18:608-625.
21. Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension. Clin Ther 1996; 18:411-428.
22. Marsh EE, Biller J, Adams HP, Marler JR, Hulbert JR, Love BB, Gordon DL. Orcadian variation in onset of acute ischemic stroke. Arch Neurol 1990; 47:1178-1180.
23. Muller JE, Tofler GH, Stone PH. Orcadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733-743.
24. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60:801-806.
25. Khoury AF, Sunderajan P, Kaplan NM. The early morning rise in blood pressure is related mainly to ambulation. Am J Hypertens 1992; 5:339-344.
26. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113:1489-1494.
27. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1991; 121:172-177.